| Literature DB >> 31340443 |
Yuan Kei Ching1, Yit Siew Chin2,3, Mahenderan Appukutty4, Vasudevan Ramanchadran5, Choo Yee Yu6, Geik Yong Ang4,6, Wan Ying Gan1, Yoke Mun Chan1,7, Lay Kek Teh6, Mohd Zaki Salleh6.
Abstract
Fatty acid desaturase 1 (FADS1) gene controls the fatty acid metabolism pathway in the human body. The lower intake of α-linolenic acid (ALA) than linoleic acid (LA) among vegetarians may disrupt the fatty acid metabolism and limit the conversion of ALA to anti-inflammatory products such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). This cross-sectional study aimed to determine the interaction of rs174547 in FADS1 gene with LA and ALA on metabolic syndrome (MetS) components. A total of 200 Chinese and Indian vegetarians in Kuala Lumpur and Selangor, Malaysia participated in the present study. The data on socio-demographic characteristics, vegetarianism practices, dietary practices, anthropometric measurements, blood pressure (BP), and overnight venous fasting blood samples were collected from the vegetarians. The rs174547 in FADS1 gene was significantly associated with MetS and its components such as waist circumference (WC) and fasting blood glucose (FBG). Multiple logistic regression analyses revealed that vegetarians with TT genotype of rs174547 in FADS1 gene had higher odds for MetS, larger WC, higher BP, and a lower level of HDL-c. Two-way ANOVA analysis showed that LA interacts with rs174547 in FADS1 gene to affect HDL-c (p < 0.05) among vegetarians. The present findings suggest the need to develop dietary guidelines for vegetarians in Malaysia. Prospective studies are also needed to affirm the interaction between LA and rs174547 in FADS1 gene on HDL-c among Malaysian vegetarians.Entities:
Keywords: fatty acid desaturase 1 gene; linoleic acid; metabolic syndromes; single nucleotide polymorphism; vegetarians; α-linolenic acid
Year: 2019 PMID: 31340443 PMCID: PMC6682884 DOI: 10.3390/nu11071686
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Representative genotyping data for C allele (144 bp). Note: M: 100 bp DNA Ladder; bp: base pair; -ve: negative control; +ve: positive control.
Figure 2Representative genotyping data for T allele (191 bp). Note: M: 100 bp DNA Ladder; bp: base pair; -ve: negative control; +ve: positive control.
Socio-demographic, vegetarianism practices, and genotype distribution of rs174547 in FADS1 gene of vegetarians (n = 200).
| Variable | Mean ± SD | |
|---|---|---|
|
| 48.3 ± 13.2 | |
|
| ||
| Male | 69 (34.5) | |
| Female | 131 (65.5) | |
|
| ||
| Chinese | 126 (63.0) | |
| Indians | 74 (37.0) | |
|
| 13.7 ± 9.2 | |
|
| ||
| Vegans | 38 (19.0) | |
| Lacto vegetarians | 52 (26.0) | |
| Ovo vegetarians | 14 (7.0) | |
| Lacto-ovo vegetarians | 96 (48.0) | |
|
| ||
| CC | 57 (28.50) | |
| CT | 64 (32.0) | |
| TT | 79 (39.5) |
Energy, macronutrients, fibre and dietary fats intake of vegetarians (n = 200).
| Variables | Mean ± SD | |
|---|---|---|
|
≠
| 7263 ± 1884 | |
| % RNI | 87.9 ± 21.1 | |
| <RNI | 151 (75.5) | |
| ≥RNI | 49 (24.5) | |
|
≠
| 264.9 ± 74.7 | |
| <50.0% | 11 (5.5) | |
| 50.0–65.0% | 131 (65.5) | |
| >65.0% | 58 (29.0) | |
|
≠
| 49.3 ± 15.1 | |
| <10.0% | 51 (25.5) | |
| 10.0–20.0% | 149 (74.5) | |
| >20.0% | 0 (0.0) | |
|
≠
| 57.1 ± 19.7 | |
| <25.0% | 49 (24.5) | |
| 25.0–30.0% | 64 (32.0) | |
| >30.0% | 87 (43.5) | |
|
| 26.0 ± 10.5 | |
|
| 112.7 ± 119.6 | |
|
| 25.3 ± 11.1 | |
|
| 18.2 ± 6.2 | |
|
⏀
| 7.6 (6.2–10.6) | |
|
| 7.9 ± 3.6 | |
|
⏀
| 0.5 (0.4–0.8) |
Note: RNI: recommended nutrient intake; kJ: kilojoule; MUFA: monounsaturated fatty acid; PUFA: polyunsaturated fatty acid, LA: linoleic acid; ALA: α-linolenic acid. Variables are presented as Mean ± SD, and as n (%). ≠ Variables are presented in Mean ± SD. ⏀ Variables are presented in Median (IQR).
Characteristics of the MetS and its components based on rs174547 in FADS1 gene (n = 200).
| Variable | CC ( | CT ( | TT ( | Total (n = 200) | ||
|---|---|---|---|---|---|---|
|
≠
| ||||||
| Mean ± SD | 76.6 ± 8.7 | 78.7 ± 10.8 | 84.8 ± 12.5 | 80.5 ± 11.5 | 11.01 | 0.0001 * |
| Normal WC | 51 (89.5) | 43 (67.2) | 35 (44.3) | 129 (64.5) | 29.80 | 0.0001 * |
| Large WC | 6 (10.5) | 21 (32.8) | 44 (55.7) | 71 (35.5) | ||
|
≠
| ||||||
| Mean ± SD | 126.4 ± 20.9 | 128.5 ± 17.0 | 127.8 ± 17.8 | 127.6 ± 18.4 | 0.21 | 0.811 |
| Normal SBP | 33 (57.9) | 34 (53.1) | 39 (49.4) | 106 (53.0) | 0.97 | 0.617 |
| High SBP | 24 (42.1) | 30 (46.9) | 40 (50.6) | 94 (47.0) | ||
|
≠
| ||||||
| Mean ± SD | 76.3 ± 11.9 | 76.3 ± 9.7 | 74.2 ± 10.8 | 75.5 ± 10.8 | 0.92 | 0.399 |
| Normal DBP | 42 (73.7) | 52 (81.2) | 64 (81.0) | 158 (79.0) | 1.36 | 0.507 |
| High DBP | 15 (26.3) | 12 (18.8) | 15 (19.0) | 42 (21.0) | ||
|
| ||||||
| No | 32 (56.1) | 31 (48.4) | 38 (48.1) | 101 (50.5) | 1.02 | 0.602 |
| Yes | 25 (43.9) | 33 (51.6) | 41 (51.9) | 99 (49.5) | ||
|
⏀
| ||||||
| Median (IQR) | 4.7 (4.4–5.1) | 4.7 (4.4–5.0) | 4.9 (4.4–5.5) | 4.7 (4.4–5.2) | 3.14 | 0.082 |
| Normal | 49 (86.0) | 59 (92.2) | 61 (77.2) | 169 (84.5) | 6.18 | 0.045 * |
| High FBG | 8 (14.0) | 5 (7.8) | 18 (22.8) | 31 (15.5) | ||
|
⏀
| ||||||
| Median (IQR) | 1.2 (0.8–1.8) | 0.9 (0.7-1.5) | 1.1 (0.7–1.8) | 1.1 (0.8–1.7) | 4.99 | 0.208 |
| Normal TG | 41 (71.9) | 50 (78.1) | 57 (72.2) | 148 (74.0) | 0.83 | 0.659 |
| High TG | 16 (28.1) | 14 (21.9) | 22 (27.8) | 52 (26.0) | ||
| ≠ | ||||||
| Mean ± SD | 1.3 ± 0.2 | 1.3 ± 0.3 | 1.2 ± 0.3 | 1.3 ± 0.3 | 3.76 | 0.025 * |
| Normal HDL-c | 45 (78.9) | 47 (73.4) | 48 (60.8) | 140 (70.0) | 5.75 | 0.057 |
| Low HDL-c | 12 (21.1) | 17 (26.6) | 31 (39.2) | 60 (30.0) | ||
|
≠
| ||||||
| Mean ± SD | 1.2 ± 1.1 | 1.4 ± 1.0 | 2.0 ± 1.4 | 1.6 ± 1.2 | 8.29 | 0.0001 * |
| No | 50 (87.7) | 54 (84.4) | 54 (68.4) | 158 (79.0) | 9.12 | 0.010 * |
| Yes | 7 (12.3) | 10 (15.6) | 25 (31.6) | 42 (21.0) |
Note: WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic blood pressure; BP: blood pressure; FBG: fasting blood glucose; TG: triglyceride; HDL-c: high-density lipoprotein cholesterol; MetS: metabolic syndrome. The genotypes of rs174547 in FADS1 gene (CC, CT and TT) are independent variables, whilst MetS and its components (large waist circumference, high blood pressure, high fasting blood glucose, high triglyceride, and low level of high-density lipoprotein cholesterol) are dependent variables. ≠ Variables are presented as Mean ± SD, and tested by one-way ANOVA with value reported in F and p. ⏀ Variables are presented as median (IQR), and tested by Kruskal–Wallis test with value reported in and p. * Indicates a significant difference at p < 0.05.
Multiple logistic regression analysis (n = 200).
| Genotype | a MetS | b Large WC | c High BP | d High FBG | e High TG | f Low HDL-c |
|---|---|---|---|---|---|---|
| CC | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| CT | 1.53 | 3.84 | 2.04 | 0.63 | 0.71 | 1.39 |
| TT | 3.57 | 4.73 | 3.17 | 2.04 | 0.78 | 3.82 |
Note: WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic blood pressure; BP: blood pressure; FBG: fasting blood glucose; TG: triglyceride; HDL-c: high-density lipoprotein cholesterol; MetS: metabolic syndrome. Six different multiple logistic regression models (a, b, c, d, e and f) were used to predict the odds ratio of developing MetS, large WC, high BP, high FBG, high TG and low level of HDL-c. All models of multiple logistic regression analysis adjusted odds ratios (95% confidence interval) are shown after adjustment for age, sex and ethnicity. * Indicates a significant difference at p < 0.05.
Interaction between rs174547 in FADS1 gene and LA intake on MetS components (n = 200).
| Variables | LA (g/day) Low (≤5.86) ( | LA (g/day) Medium (5.87–8.19) ( | LA (g/day) High (≥8.20) ( | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Genotype | Mean ± SD | Genotype | Mean ± SD | Genotype | Mean ± SD | |||||
| WC (cm) | CC ( | 78.9 ± 10.4 | 0.020 * | CC ( | 77.3 ± 9.4 | 0.016 * | CC ( | 74.5 ± 6.6 | 0.009 * | 0.177 |
| CT ( | 77.3 ± 11.4 | CT ( | 76.3 ±8.1 | CT ( | 83.1 ± 12.0 | |||||
| TT ( | 85.3 ± 9.8 | TT ( | 85.3 ±15.1 | TT ( | 83.7 ±13.1 | |||||
| SBP (mmHg) | CC ( | 129.4 ± 19.4 | 0.467 | CC ( | 130.4 ± 23.5 | 0.722 | CC ( | 121.0 ± 19.3 | 0.611 | 0.535 |
| CT ( | 135.4 ± 21.1 | CT ( | 126.0 ± 14.4 | CT ( | 123.2 ± 11.1 | |||||
| TT ( | 128.5 ± 20.7 | TT ( | 129.6 ± 18.9 | TT ( | 125.3 ± 12.9 | |||||
| DBP (mmHg) | CC ( | 76.9 ± 11.9 | 0.350 | CC ( | 78.1 ± 13.4 | 0.811 | CC ( | 74.5 ± 10.8 | 0.904 | 0.882 |
| CT ( | 77.9 ± 10.8 | CT ( | 76.2 ± 7.9 | CT ( | 74.5 ± 10.4 | |||||
| TT ( | 73.4 ± 11.8 | TT ( | 76.0 ± 11.4 | TT ( | 73.4 ± 9.1 | |||||
| Log FBG (mmol/L) | CC ( | 0.7 ± 0.1 | 0.373 | CC ( | 0.7 ± 0.05 | 0.004 * | CC ( | 0.7 ± 0.1 | 0.459 | 0.807 |
| CT ( | 0.7 ± 0.04 | CT ( | 0.7 ± 0.04 | CT ( | 0.7 ± 0.03 | |||||
| TT ( | 0.7 ± 0.1 | TT ( | 0.7 ± 0.1 | TT ( | 0.7 ± 0.1 | |||||
| HDL-c (mmol/L) | CC ( | 1.2 ± 0.2 | 0.213 | CC ( | 1.4 ± 0.3 | 0.001 * | CC ( | 1.3 ± 0.2 | 0.205 | 0.005* |
| CT ( | 1.4 ± 0.3 | CT ( | 1.4 ± 0.3 | CT ( | 1.2 ± 0.2 | |||||
| TT ( | 1.3 ± 0.3 | TT ( | 1.1 ± 0.3 | TT ( | 1.2 ± 0.3 | |||||
| Log TG (mmol/L) | CC ( | 0.2 ± 0.3 | 0.101 | CC ( | 0.01 ± 0.2 | 0036 * | CC ( | 0.1 ± 0.3 | 0.460 | 0.075 |
| CT ( | 0.1 ±0.2 | CT | −0.1 ± 0.1 | CT ( | 0.1 ±0.3 | |||||
| TT ( | 0.1 ± 0.2 | TT ( | 0.1 ± 0.3 | TT ( | 0.02 ± 0.3 | |||||
Note: WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic blood pressure; FBG: fasting blood glucose; HDL-c: high-density lipoprotein cholesterol; TG: triglyceride; LA: linoleic acid. Data are presented as Mean ± SD, and tested by One-Way ANOVA analysis with value in p. Gene-diet interaction analysis tested by Two-Way AVOVA analysis with p-interaction term. * Indicates a significant difference at p < 0.05.
Interaction between rs174547 in FADS1 gene and ALA intake on MetS components (n = 200).
| Variables | ALA Low (≤0.45) ( | ALA Medium (0.46–0.64) ( | ALA High (≥0.65) ( | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Genotype | Mean ± SD | Genotype | Mean ± SD | Genotype | Mean ± SD | |||||
| WC (cm) | CC ( | 79.5 ± 10.7 | 0.035 * | CC ( | 77.7 ± 5.8 | 0.009 * | CC ( | 72.7 ± 7.2 | 0.004 * | 0.258 |
| CT ( | 76.5 ± 10.9 | CT ( | 79.2 ± 10.6 | CT ( | 80.9 ± 11.1 | |||||
| TT ( | 84.8 ± 11.9 | TT | 86.0 ± 10.4 | TT ( | 83.7 ± 14.7 | |||||
| SBP (mmHg) | CC ( | 133.5 ± 20.8 | 0.531 | CC ( | 122.4 ± 16.6 | 0.391 | CC ( | 122.1 ± 22.9 | 0.558 | 0.434 |
| CT ( | 130.4 ± 22.1 | CT ( | 128.6 ± 13.8 | CT ( | 125.8 ± 12.5 | |||||
| TT ( | 126.6 ± 19.2 | TT ( | 129.3 ± 18.6 | TT ( | 127.6 ± 16.4 | |||||
| DBP (mmHg) | CC ( | 79.1 ± 13.5 | 0.264 | CC ( | 76.0 ± 9.3 | 0.272 | CC ( | 73.7 ± 11.9 | 0.981 | 0.413 |
| CT ( | 75.0 ± 9.6 | CT ( | 79.5 ± 9.6 | CT ( | 73.9 ± 9.4 | |||||
| TT ( | 73.8 ± 11.2 | TT ( | 74.6 ± 11.9 | TT ( | 74.2 ± 9.9 | |||||
| Log FBG (mmol/L) | CC ( | 0.7 ± 0.1 | 0.754 | CC ( | 0.7 ± 0.1 | 0.097 | CC ( | 0.7 ± 0.04 | 0.019 * | 0.293 |
| CT ( | 0.7 ± 0.03 | CT ( | 0.7 ± 0.04 | CT ( | 0.7 ± 0.04 | |||||
| TT ( | 0.7 ± 0.1 | TT ( | 0.7 ± 0.1 | TT ( | 0.7 ± 0.1 | |||||
| HDL-c (mmol/L) | CC ( | 1.3 ± 0.2 | 0.200 | CC ( | 1.3 ± 0.3 | 0.043 * | CC ( | 1.3 ± 0.2 | 0.254 | 0.230 |
| CT ( | 1.4 ± 0.4 | CT ( | 1.3 ± 0.3 | CT ( | 1.2 ± 0.2 | |||||
| TT ( | 1.3 ± 0.3 | TT ( | 1.2 ± 0.3 | TT ( | 1.2 ± 0.3 | |||||
| Log TG (mmol/L) | CC ( | 0.2 ± 0.3 | 0.212 | CC ( | 0.1 ± 0.2 | 0.226 | CC ( | 0.1 ± 0.2 | 0.981 | 0.410 |
| CT ( | 0.04 ± 0.3 | CT ( | −0.02 ± 0.2 | CT ( | 0.1 ± 0.2 | |||||
| TT ( | 0.04 ± 0.2 | TT ( | 0.1 ± 0.3 | TT ( | 0.1 ± 0.3 | |||||
Note: WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic blood pressure; FBG: fasting blood glucose; HDL-c: high-density lipoprotein cholesterol; TG: triglyceride; ALA: α-linolenic acid. Data are presented as Mean ± SD, and tested by One-Way ANOVA analysis with value in p. Gene-diet interaction analysis tested by Two-Way AVOVA analysis with p-interaction term. * Indicates a significant difference at p < 0.05.